Unrated Drug recall · FDA · Published March 29, 2019

Jubilant Recalls Pantoprazole Tablets Due to Discoloration

Jubilant Cadista recalls 12,960 bottles of Pantoprazole Sodium Delayed-Release Tablets due to dark brown discoloration on tablet edges.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-1074-2019Drug Jubilant Cadista ›

Recall notice

Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets.

Take action

Contact the company

Recalling firmJubilant Cadista Pharmaceuticals, Inc.207 Kiley Dr · Salisbury, MD 21801-2249

✎ GovInfoNow plain-language explainer

Jubilant Cadista Pharmaceuticals is recalling a specific lot of Pantoprazole Sodium Delayed-Release Tablets because the tablets show dark brown discoloration on their edges. This recall expands upon an earlier notice regarding the same issue. The affected product was distributed nationwide in the United States. Read more at govinfonow.com/recall/39064-jubilant-recalls-pantoprazole-tablets-due-to-discoloration.

Source Summary by GovInfoNow · govinfonow.com/recall/39064-jubilant-recalls-pantoprazole-tablets-due-to-discoloration · Updated October 11, 2026 · FDA enforcement record: FDA #D-1074-2019

Cite this page

“Jubilant Recalls Pantoprazole Tablets Due to Discoloration.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/39064-jubilant-recalls-pantoprazole-tablets-due-to-discoloration. Based on FDA recall #D-1074-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1074-2019%22&limit=1).

The FDA announced on March 29, 2019, that Jubilant Cadista Pharmaceuticals, Inc. voluntarily recalled Pantoprazole Sodium Delayed-Release Tablets due to dark brown discoloration. The agency classified the recall as Class II.

How to tell if you have it

Brand: Jubilant Cadista
Product: Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle
NDC: 59746-284-90
Lot #: PA217060A
Expiration: 05/2020

The hazard

The recall addresses the presence of dark brown discoloration on the edges of the tablets. This action expands an earlier recall regarding the same issue.

Context

GovInfoNow's records show Jubilant Cadista Pharmaceuticals, Inc. has had 24 other recalls since February 11, 2013. Recent brand recalls include a December 27, 2022 subpotent drug risk for Prochlorperazine Tablets and a July 18, 2022 recall of Irbesartan tablets due to failed dissolution. Other recent recalls of similar products include Hetero Labs Pantoprazole Tablets Recall (March 26, 2026) and JB Chemicals Recalls Cetirizine Tablets Due to Cross-Contamination (June 24, 2026).

How to tell if you have this one

Check your medication bottle for the following details: Brand 'Jubilant Cadista' or 'Jubilant Generics', NDC 59746-284-90, Lot number PA217060A, and an expiration date of 05/2020. The product is a 40 mg, Rx-only, 90-count bottle of Pantoprazole Sodium Delayed-Release Tablets.

Brand
Jubilant Cadista
Category
Drug

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 6 months after the firm started it.

Mar 29, 2019Firm started the recall
Apr 1, 2019FDA classified it Class II
Apr 10, 2019Published in FDA’s Enforcement Report
Sep 20, 2019FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/39064-jubilant-recalls-pantoprazole-tablets-due-to-discoloration">Jubilant Recalls Pantoprazole Tablets Due to Discoloration (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-1074-2019 (March 29, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1074-2019 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.